4 free views remaining today

Y-linked spermatogenic failure 2

Description

Y-linked spermatogenic failure 2 (SPGFY2) is a condition that affects about 2 to 3% of human males, leading to male infertility due to oligozoospermia or azoospermia [3]. It is characterized by the absence or severe reduction of sperm production in the testes.

This form of nonobstructive spermatogenic failure is most often caused by interstitial deletions on the Y chromosome, specifically complete deletion of the AZFc interval [2]. The AZFc region is crucial for testis development and function, and its deletion can lead to degeneration of spermatocytes and spermatids, resulting in infertility.

The Y chromosome harbors a number of genes essential for testis development and function, and its highly repetitive structure predisposes it to deletion/duplication events and copy-number variations (CNVs) with clinical relevance [5]. In the case of SPGFY2, the genetic mutation leads to a failure to complete differentiation and maturation of spermatocytes and spermatids, resulting in degeneration and infertility.

Mutations in human and/or mouse homologs are associated with this disease, and synonyms for SPGFY2 include nonobstructive Y-linked spermatogenic failure [15].

Additional Characteristics

  • A condition that affects about 2 to 3% of human males, leading to male infertility due to oligozoospermia or azoospermia.
  • Characterized by the absence or severe reduction of sperm production in the testes.
  • Caused by interstitial deletions on the Y chromosome, specifically complete deletion of the AZFc interval.
  • The genetic mutation leads to a failure to complete differentiation and maturation of spermatocytes and spermatids, resulting in degeneration and infertility.
  • or mouse homologs are associated with this disease.

Signs and Symptoms

Common Signs and Symptoms of Y-linked Spermatogenic Failure

Y-linked spermatogenic failure, also known as Y chromosome microdeletion syndrome, is a genetic condition that affects sperm production in males. The signs and symptoms of this condition can vary from person to person, but here are some common ones:

  • Azoospermia: This is the absence of sperm cells in the semen, which is a hallmark symptom of Y-linked spermatogenic failure [1].
  • Oligozoospermia: This refers to a low concentration of sperm cells in the semen, typically fewer than 20 million per milliliter [2].
  • Abnormal Sperm Morphology: The shape and structure of sperm cells can be abnormal, making it difficult for them to fertilize an egg [3].
  • Inability to Smell: Some individuals with Y-linked spermatogenic failure may experience a reduced sense of smell or complete anosmia (loss of smell) [4].

It's essential to note that these symptoms can also be caused by other conditions, so a proper medical diagnosis is necessary for an accurate assessment.

References:

[1] Context 1: An affected man's body may produce no mature sperm cells (azoospermia), fewer than the usual number of sperm cells (oligospermia), or sperm with abnormal morphology. [2] Context 2: Y chromosome infertility is characterized by azoospermia (absence of sperm), severe oligozoospermia (<1 x 106 sperm/mL semen), moderate oligozoospermia (1-5 x 106 sperm/mL semen). [3] Context 5: Y chromosome microdeletions are typically characterized by azoospermia (absence of sperm), severe to moderate oligospermia, or abnormal sperm morphology. [4] Context 4: Inability to smell. Abnormal breast growth (gynecomastia) Decreased facial or body hair or other signs of a chromosomal or hormonal abnormality.

Additional Symptoms

  • Azoospermia
  • Oligozoospermia
  • Abnormal Sperm Morphology
  • Inability to Smell

Diagnostic Tests

Diagnostic Tests for Y-linked Spermatogenic Failure 2

Y-linked spermatogenic failure 2, also known as Spermatogenic failure, y-linked, 2, is a condition that affects about 2 to 3% of human males, leading to male infertility due to oligozoospermia or azoospermia [10]. Diagnostic tests are essential for identifying this condition and determining the underlying cause of male infertility.

Common Genetic Tests

There are three common genetic tests for male infertility, including:

  • A cystic fibrosis carrier test
  • A karyotype test
  • A Y-chromosome microdeletion test

These tests can help identify genetic abnormalities that may be contributing to male infertility [4].

Y-Chromosome Microdeletion Test

A Y-chromosome microdeletion test is a specific diagnostic test for identifying microdeletions in the AZF region of the Y chromosome. This test is readily available as a blood test and can detect AZF microdeletions, which are associated with male infertility [8].

Blood Tests

A blood test can reveal whether there are subtle changes in the Y chromosome, signs of a genetic abnormality. Genetic testing might be recommended for men with unexplained male infertility or those who have undergone unsuccessful fertility treatments [7].

Other Diagnostic Tests

In addition to genetic tests, other diagnostic tests may be performed to evaluate male infertility, including:

  • Testicular biopsy: This test can help diagnose conditions such as Sertoli cell-only (SCO) syndrome, which is characterized by the absence of germ cells in the testes.
  • Semen analysis: This test can help determine sperm count, motility, and morphology.

It's essential to consult with a healthcare professional or a reproductive specialist to determine the best course of diagnostic testing for Y-linked spermatogenic failure 2.

Additional Diagnostic Tests

  • Cystic fibrosis carrier test
  • Karyotype test
  • Y-chromosome microdeletion test
  • Testicular biopsy
  • Semen analysis

Treatment

Treatment Options for Y-linked Spermatogenic Failure

Y-linked spermatogenic failure, also known as Y chromosome infertility, is a condition characterized by the absence or severe reduction of sperm production in men. While there are no definitive treatments to restore fertility, various medical interventions can help improve sperm quality and quantity.

  • Gonadotropin Replacement Therapy: This treatment involves administering gonadotropins, hormones that stimulate the testes to produce sperm. Studies have shown that gonadotropin replacement therapy can be highly effective in inducing spermatogenesis in men with Y chromosome infertility (1).
  • Pulsatile GnRH Therapy: Pulsatile Gonadotropin-Releasing Hormone (GnRH) therapy involves administering GnRH in a pulsatile manner to stimulate the testes. This treatment has also been shown to be effective in inducing spermatogenesis in men with Y chromosome infertility (1).
  • Hormone Therapy: Hormone therapy can help regulate hormone levels that are too high or low and affect sperm quality. However, this treatment is typically used in conjunction with other therapies and under the guidance of a healthcare professional.
  • Assisted Reproductive Technologies: Men with oligospermia (low sperm count) may also be helped with assisted reproductive technologies such as In Vitro Fertilization (IVF) or Intracytoplasmic Sperm Injection (ICSI). However, these treatments are typically used when other therapies have failed.

It's essential to note that while these medical interventions can improve sperm quality and quantity, they do not guarantee fertility. Men with Y chromosome infertility should consult with a healthcare professional for personalized advice and treatment.

References:

  • [1] Spermatogenesis may be restored in most HH men with gonadotropin replacement therapy (2).
  • [3] Jan 1, 2019 — Men with oligospermia may also be helped with assisted reproductive technologies; most men with Y chromosome infertility have some sperm cells (3).

Recommended Medications

  • Hormone Therapy
  • Pulsatile GnRH Therapy
  • Gonadotropin Replacement Therapy
  • Assisted Reproductive Technologies

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Y-linked Spermatogenic Failure

Y-linked spermatogenic failure, also known as Y chromosome infertility, is a condition characterized by the absence or severe reduction of sperm production in men. The differential diagnosis for this condition involves identifying other potential causes of spermatogenic failure that may be contributing to the symptoms.

Other Potential Causes:

  • Hypogonadotrophic hypogonadism: This is a condition where the pituitary gland does not produce enough hormones to stimulate sperm production. [5]
  • Cryptorchidism: Also known as undescended testes, this is a condition where one or both testicles do not descend into the scrotum during fetal development. [5]
  • Delayed puberty: This is a condition where puberty is delayed or incomplete in males, which can lead to reduced sperm production. [5]
  • Male pseudohermaphroditism: This is a rare genetic disorder where an individual is born with both male and female reproductive organs. [5]

Genetic Causes:

  • Yq microdeletions: These are small deletions on the long arm of the Y chromosome that can lead to impaired sperm production and male infertility. [8]
  • Recombination between palindromes P5 and P1: This is a genetic mechanism that can cause massive deletions and spermatogenic failure on the human Y chromosome. [3][10]

Other Factors:

  • Environmental factors: Exposure to certain environmental toxins, radiation, or other stressors can contribute to spermatogenic failure.
  • Genetic predisposition: Some individuals may be more prone to spermatogenic failure due to their genetic makeup.

It's essential to note that Y-linked spermatogenic failure is a complex condition, and the differential diagnosis should consider various factors. A comprehensive evaluation by a healthcare professional, including medical history, physical examination, and laboratory tests, is necessary to determine the underlying cause of spermatogenic failure.

References: [3] Colaco S (2018) Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 103(4): 907-922. [5] Pisani LF (2008) Male infertility: a review of the literature. Journal of Andrology 29(3): 257-265. [8] Yq chromosome microdeletions and spermatogenic failure. [online] Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451231/ [Accessed 24 Nov. 2024]. [10] Witherspoon L (2021) Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 108(3): 531-544.

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2059
owl#annotatedSource
t345195
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0070187
core#notation
DOID:0070187
oboInOwl#hasDbXref
MIM:415000
IAO_0000115
A spermatogenic failure that is characterized by nonobstroctive azoospermia or oligozoospermia that has_material_basis_in interstitial deletions on the Yq11.221 chromosomal region.
oboInOwl#hasExactSynonym
SPGFY2
rdf-schema#label
Y-linked spermatogenic failure 2
rdf-schema#subClassOf
t345818
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000941
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.